Top Markets
#1 CyberDEX CyberDEX +281.44%
#2 PulseChain PulseChain +51.36%
#3 DogBull DogBull +47.73%
#4 Amp Amp +47.25%
#5 Quack AI Quack AI +46.72%
#6 Zano Zano +26.41%
#7 DoubleZero DoubleZero +21.80%
#8 Jelly-My-Jelly Jelly-My-Jelly +14.34%
#9 Black Phoenix Black Phoenix +14.21%
#10 Pearl Pearl +13.51%
Coin of the day
CyberDEX CyberDEX
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
OptiBiotix Health Plc OptiBiotix Health Plc

OptiBiotix Health Plc

OPTI
Classifica tra le azioni #40732
OptiBiotix Health Plc, a life sciences enterprise headquartered in York, United... OptiBiotix Health Plc, a life sciences enterprise headquartered in York, United Kingdom, specializes in the discovery and advancement of microbiome-modulating technologies. The company formulates distinct microbial strains, innovative compounds, and tailored blends intended for integration into food products, nutritional supplements, and active ingredients. Their groundbreaking work aims to positively influence human physiology and yield substantial health benefits. Among its diverse product portfolio are Slimbiome, a natural ingredient for healthy and satiety-driven weight management, and SlimBiome Medical, a supplemental aid for weight control. Other offerings include CholBiome, a dietary supplement for maintaining healthy cholesterol; Lactobacillus plantarum LPLDL, a probiotic supporting cardiovascular health and overall well-being; LPGOS, a galactooligosaccharide utilized in food applications to mitigate cardiovascular risk factors and enhance general health; WellBiome, a functional fiber and mineral blend designed to bolster gut microbiome diversity and promote wellness; and Sweetbiotix, a sweetener for use in various foods and beverages. Ultimately, OptiBiotix's innovations are designed to prevent and manage prevalent chronic lifestyle diseases, including obesity, high cholesterol, and diabetes. The company was founded in 2012.
Prezzo delle azioni
$0.07994122
Ultima sincronizzazione: 2026-09-25
Capitalizzazione di mercato
$82.58K
Variazione (1 giorno)
0.43%
Variazione (1 anno)
-44.51%
Paese
GB
Scambia OptiBiotix Health Plc (OPTI)

Categoria

Healthcare
Ricavi di OptiBiotix Health Plc (OPTI)
Ricavi nel Jun 2026 TTM: $1.75M
Secondo gli ultimi rapporti finanziari di OptiBiotix Health Plc, i ricavi attuali dell'azienda (TTM) sono pari a $1.75M. Nel 2023, l'azienda ha registrato ricavi di $819.81K un aumento rispetto a i ricavi dell'anno 2022, che erano pari a $552.88K. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per OptiBiotix Health Plc da 2007 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $1.75M 60.54%
2024 $1.09M 33.16%
2023 $819.81K 48.28%
2022 $552.88K -81.52%
2021 $2.99M 43.69%
2020 $2.08M 110.80%
2019 $987.78K 50.50%
2018 $656.34K 153.86%
2017 $258.54K -28.31%
2016 $360.63K 749.11%
2015 $42.47K 0.00%
2014 0.00 0.00%
2013 0.00 -100.00%
2012 $253.34K 114.67%
2011 $118.01K 0.00%
2010 0.00 0.00%
2009 0.00 0.00%
2008 0.00 0.00%
2007 0.00 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 720,225.13%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B 127,026.60%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 343,466.34%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B 898,249.57%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH